Urolithin a attenuates IL-1β-induced inflammatory responses and cartilage degradation via inhibiting the MAPK/NF-κB signaling pathways in rat articular chondrocytes
Open Access
- 24 March 2020
- journal article
- research article
- Published by Springer Nature in Journal of Inflammation
- Vol. 17 (1) , 1-13
Abstract
Background: Osteoarthritis (OA) is characterized by inflammation and extracellular matrix (ECM) degradation and is one of the most common chronic degenerative joint diseases that causes pain and disability in adults. Urolithin A (UA) has been widely reported for its anti-inflammatory properties in several chronic diseases. However, the effects of UA on OA remain unclear. The aim of the current study was to investigate the anti-inflammatory effects and mechanism of UA in interleukin-1β (IL-1β)-induced chondrocytes. Results: No marked UA cytotoxicity was noted, and UA protected cartilage from damage following IL-1β stimulation in micromasses. Moreover, UA promoted the expression of anabolic factors including Sox-9, Collagen II, and Aggrecan while inhibiting the expression of catabolic factors such as matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAMTS-4) in rat chondrocytes. Protective effects of UA were also observed in ex vivo organ culture of articular cartilage. Mechanistically, IL-1β significantly activated and upregulated the expression of p-ERK 1/2, p-JNK, p-P38, and p-P65, while UA protected chondrocytes against IL-1β-induced injury by activating the mitogen-activated kinase (MAPK)/nuclear factor-κB (NF-κB) signaling pathways. Conclusion: Our results provide the evidence that UA could attenuate IL-1β-induced cell injury in chondrocytes via its anti-inflammatory action. UA may be a promising therapeutic agent in the treatment of OA.Keywords
Funding Information
- Project of Qingpu District Science and Technology Commission (QKY2018-11)
- the Project of Qingpu Branch of Zhongshan Hospital (QYZ2019-02 and QY2019-04)
This publication has 45 references indexed in Scilit:
- Telmisartan directly ameliorates the neuronal inflammatory response to IL-1β partly through the JNK/c-Jun and NADPH oxidase pathwaysJournal of Neuroinflammation, 2012
- The Microbiome and Butyrate Regulate Energy Metabolism and Autophagy in the Mammalian ColonCell Metabolism, 2011
- Role of proinflammatory cytokines in the pathophysiology of osteoarthritisNature Reviews Rheumatology, 2010
- NF-κB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblastsBritish Journal of Nutrition, 2010
- Immunological and Inflammatory Functions of the Interleukin-1 FamilyAnnual Review of Immunology, 2009
- P38 MAP kinase inhibitors as potential therapeutics for the treatment of joint degeneration and pain associated with osteoarthritisJournal of Inflammation, 2008
- OsteoarthritisJournal of Cellular Physiology, 2007
- NF-κB as a potential therapeutic target in osteoarthritis and rheumatoid arthritisOsteoarthritis and Cartilage, 2006
- Role of interleukin‐1 and tumor necrosis factor α in matrix degradation of human osteoarthritic cartilageArthritis & Rheumatism, 2005
- Osteoarthritis, angiogenesis and inflammationRheumatology, 2004